Sort by
Refine Your Search
-
strong interest in developmental, cellular or molecular neurobiology, in link with human brain evolution and diseases. PhD in neuroscience, genetics, evolutionary biology or related field. Experience in
-
About the Lab The lab of Jeroen Raes (VIB, KU Leuven) is home to a vibrant, dynamic and international group of researchers in the field of gut microbial ecology and its clinical applications
-
The Laboratory of Ion Channel Research (https://voetslab.sites.vib.be/en ), led by Prof. Thomas Voets at the VIB–KU Leuven Center for Brain & Disease Research, is a dynamic hub investigating the
-
. We are looking for an individual with expertise in the following specific profiles to enhance and complement the team: Profile Ph.D. in Molecular biology or related fields. Demonstrated expertise in
-
spin-offs and start-ups, creating a natural home for researchers and their families. English is very widely spoken in the city and surrounding area. We are looking for a postdoctoral molecular biologist
-
The Laboratory for Cellular Metabolism and Metabolic Regulation (Fendt Lab) is a young and dynamic team of researchers performing cutting edge cancer metabolism research with special focus on cancer
-
temperature signalling in plants, such as the model plant Arabidopsis thaliana and the crop plants wheat and soybean. To unravel this, we focus on dynamic changes in protein phosphorylation status, since
-
the University of Antwerp as host institution. Project background Understanding the dynamics of microglia in brain disorders is critical for the future development of therapeutics. Microglia are crucial in shaping
-
to identify and characterize these compounds. Additionally, microbial cell factories will be engineered for metabolite production through pathway engineering and dynamic pathway control. The postdoctoral
-
-scale screens to study fundamental principles in molecular and complex trait genetics using microbes as model systems. Our core technology MAGESTIC (https://doi.org/10.1038/nbt.4137 ), a CRISPR/Cas9-based